de Paula Martins Wellington, Santana Laura F, Nastri Carolina O, Ferriani Fui A, de Sa Marcos F S, Dos Reis Rosana M
Departamento de Ginecologia e Obstetrícia do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Brazil.
Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):203-7. doi: 10.1016/j.ejogrb.2006.10.038. Epub 2007 Jan 4.
The objective was to compare agreement on the diagnosis of insulin resistance (IR) among insulin sensitivity indexes in both ovulatory women and those with polycystic ovary syndrome (PCOS).
In an observational study, the 75-g oral glucose tolerance test was performed in 105 women with PCOS and 51 ovulatory women. The insulin sensitivity indexes used were insulin quantitative sensitivity check index (QUICKI), 1/homeostasis model assessment-insulin resistance (1/HOMA-IR), area under curve for insulin (AUC-I), and the Matsuda insulin sensitivity index (COMP). For the IR diagnosis we used cut-off values described in recent publications (insulin >12 microIU/ml, 1/HOMA-IR <0.47, QUICKI < or =0.333, AUC-I > or =7000 microIU/ml 120 min, and COMP <4.75.
Excellent agreement was assessed among insulin, QUICKI, and 1/HOMA-IR. However, the rate of IR detected by these indexes in the PCOS group (44.8-51.4%) was lower than expected. New cut-offs were then determined based on COMP results. Using these values, 1/HOMA-IR and QUICKI showed excellent agreement (kappa=0.83) with COMP.
The observed agreements among insulin, QUICKI and 1/HOMA-IR were higher than 93%. Therefore, clinicians may choose any of those obtaining similar results. For clinicians who prefer COMP, but are looking for a simpler test to detect IR in PCOS women, the use of QUICKI and 1/HOMA-IR with the new cut-offs seems reasonable.
比较排卵正常女性和多囊卵巢综合征(PCOS)女性中胰岛素敏感性指标对胰岛素抵抗(IR)诊断的一致性。
在一项观察性研究中,对105例PCOS女性和51例排卵正常女性进行了75克口服葡萄糖耐量试验。所使用的胰岛素敏感性指标包括胰岛素定量敏感性检查指数(QUICKI)、1/稳态模型评估-胰岛素抵抗(1/HOMA-IR)、胰岛素曲线下面积(AUC-I)和松田胰岛素敏感性指数(COMP)。对于IR诊断,我们采用了近期出版物中描述的临界值(胰岛素>12微国际单位/毫升,1/HOMA-IR<0.47,QUICKI≤0.333,AUC-I>或=7000微国际单位/毫升120分钟,以及COMP<4.75)。
胰岛素、QUICKI和1/HOMA-IR之间评估出具有极佳的一致性。然而,这些指标在PCOS组中检测到的IR发生率(44.8-51.4%)低于预期。然后根据COMP结果确定了新的临界值。使用这些值时,1/HOMA-IR和QUICKI与COMP显示出极佳的一致性(kappa=0.83)。
胰岛素、QUICKI和1/HOMA-IR之间观察到的一致性高于93%。因此,临床医生可以选择获得相似结果的任何一项指标。对于更喜欢COMP但正在寻找一种更简单的检测PCOS女性IR的方法的临床医生来说,使用具有新临界值的QUICKI和1/HOMA-IR似乎是合理的。